Sintx Technologies, Inc. (SINT)
$
3.03
-0.17 (-5.61%)
Key metrics
Financial statements
Free cash flow per share
-2.5793
Market cap
8.4 Million
Price to sales ratio
6.8569
Debt to equity
0.8338
Current ratio
1.7009
Income quality
0.7467
Average inventory
401 Thousand
ROE
-3.6721
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company reported depreciation and amortization expenses of $1,384,000.00 reflecting the wear and tear of its assets. The financial data pertains to the fiscal year $2024. In addition, the company incurred an interest expense of $29,000.00 reflecting its debt servicing obligations. The EBITDA is -$9,611,000.00 a key indicator of the company's operational profitability, while the weighted average number of shares outstanding is $744,781.00 highlighting the company's shareholder base. Sintx Technologies offers solid and porous silicon nitride, silicon nitrite powder, and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company, formerly known as Amedica Corporation, was incorporated in 1996 and is headquartered in Salt Lake City, Utah. The stock is affordable at $4.93 suitable for budget-conscious investors. Furthermore, the stock has a high average trading volume of $56,108.00 indicating strong liquidity. With a market capitalization of $8,358,619.00 the company is classified as a small-cap player. Sintx Technologies is a key player in the Medical - Devices industry, contributing significantly to the overall market landscape. As it belongs to the Healthcare sector, it drives innovation and growth, positioning itself as a notable entity within its field.
Is Sintx Technologies, Inc. (SINT) a good investment?
Investing in Sintx Technologies, Inc. (SINT) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as D+, with a Bullish outlook. Always conduct your own research before investing.
What is Sintx Technologies, Inc. (SINT)'s stock forecast?
Analysts predict Sintx Technologies, Inc. stock to fluctuate between $1.71 (low) and $7.36 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Sintx Technologies, Inc.'s market capitalization?
As of 2026-02-20, Sintx Technologies, Inc.'s market cap is $8,358,619, based on 2,758,620 outstanding shares.
How does Sintx Technologies, Inc. compare to competitors like Meta Platforms, Inc. Class A Common Stock?
Compared to Meta Platforms, Inc. Class A Common Stock, Sintx Technologies, Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Sintx Technologies, Inc. (SINT) stock?
To buy Sintx Technologies, Inc. (SINT) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for SINT. Place an order (Market, Limit, etc.).
What is the best time to invest in Sintx Technologies, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Has Sintx Technologies, Inc. stock ever split?
Sintx Technologies, Inc.'s last stock split was 1:200 on 2024-05-28.
How did Sintx Technologies, Inc. perform in the last earnings report?
Revenue: $1,246,000 | EPS: -$14.87 | Growth: -58.03%.
Where can I find Sintx Technologies, Inc.'s investor relations reports?
Visit https://www.sintx.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Sintx Technologies, Inc.?
You can explore historical data from here
What is the all-time high and low for Sintx Technologies, Inc. stock?
All-time high: $36,000 (2021-08-05) | All-time low: $1.71 (2025-04-16).
What are the key trends affecting Sintx Technologies, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
globenewswire.com
Appointment supports acceleration of revenue opportunities from SiNERGY ™ silicon nitride devices and antipathogenic fibrous material technologies
globenewswire.com
Milestone enables immediate production of SiN/PEEK custom devices SALT LAKE CITY, Utah, Dec. 01, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics and biomaterials company, today announced that it has signed a supply agreement with Evonik Corporation (“EVONIK”), a global leader in high‑performance polymers, to manufacture the Company's proprietary silicon nitride–PEEK compound (SiN/PEEK) (U.S. Patent No. 10,806,831) engineered for AI‑assisted additive manufacturing of patient‑specific implants that will be produced using equipment already in place at SINTX's U.S.-based production facility.
globenewswire.com
FDA cleared and U.S. manufactured implant system positions SINTX to enter billion-dollar U.S. market SALT LAKE CITY, Utah, Oct. 20, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced ceramics specializing in biomedical applications of silicon nitride (Si₃N₄), today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the SINAPTIC® Foot & Ankle Osteotomy Wedge System, enabling SINTX's commercial entry into reconstructive foot and ankle surgery in the United States. SINTX plans a U.S. commercial launch in Q1 2026, leveraging its U.S.-based manufacturing to drive revenue acceleration and operating efficiency.
zacks.com
Does SINTX TECHNOLOGIES, INC. (SINT) have what it takes to be a top stock pick for momentum investors?
globenewswire.com
Significant Development in the Estimated $30 Billion Global Infection-Prevention Market SALT LAKE CITY, Utah, Sept. 08, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance (PTOL-85) for its patent application titled, “Antipathogenic Fibrous Materials.
globenewswire.com
Company Reinforces Commercialization Focus and Strategic Direction SALT LAKE CITY, Utah, Aug. 15, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics innovator specializing in silicon nitride (Si₃N₄) for medical device applications, today issued a business update in connection with the filing of the Company's Quarterly Report on Form 10-Q for the period ended June 30, 2025, filed with the Securities and Exchange Commission and available at www.sec.gov. The business update highlights meaningful progress from the Company's recent SiNAPTIC acquisition, decisive strategic transformation, and a revitalized commercialization strategy aimed at accelerating growth over the next twelve to twenty-four months.
globenewswire.com
Strategic Acquisition Brings Patented Implant Designs, Seasoned Executive Team, and Near-Term Commercial Opportunities
globenewswire.com
Strategic Transaction Enhances Financial Flexibility and Supports Growth in Healthcare Innovations Salt Lake City, UT, Feb. 20, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT), a leader in advanced ceramics for medical applications, today announced the sale of its wholly-owned subsidiary, Technology Assessment and Transfer (TA&T), to Tethon Corporation DBA Tethon 3D (Tethon). This transaction marks a significant step in SINTX's ongoing transformation, allowing the Company to sharpen its focus on high-growth opportunities in the medical device sector while improving its financial position and operational efficiency.
See all news
